Common Stock and Stock-Based Incentive Compensation Plans (Tables)
|
12 Months Ended |
Dec. 30, 2023 |
Share-Based Payment Arrangement [Abstract] |
|
Schedule of Common Shares Outstanding |
Shares of common stock outstanding were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
December 30, 2023 |
|
December 31, 2022 |
|
December 25, 2021 |
|
(In millions) |
Balance, beginning of period |
1,612 |
|
|
1,207 |
|
|
1,211 |
|
Common stock issued in the acquisition of Xilinx |
— |
|
|
429 |
|
|
— |
|
Common stock issued under employee equity plans |
17 |
|
|
17 |
|
|
12 |
|
Repurchases of common stock |
(10) |
|
|
(36) |
|
|
(17) |
|
Common stock repurchases for tax withholding on equity awards |
(4) |
|
|
(5) |
|
|
(2) |
|
Issuance of common stock upon warrant exercise |
1 |
|
|
— |
|
|
— |
|
Issuance of common stock to settle convertible debt |
— |
|
|
— |
|
|
3 |
|
|
|
|
|
|
|
Balance, end of period |
1,616 |
|
|
1,612 |
|
|
1,207 |
|
|
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs |
Stock-based compensation expense was allocated in the consolidated statements of operations as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
December 30, 2023 |
|
December 31, 2022 |
|
December 25, 2021 |
|
(In millions) |
Cost of sales |
$ |
30 |
|
|
$ |
29 |
|
|
$ |
5 |
|
Research and development |
1,002 |
|
|
697 |
|
|
246 |
|
Marketing, general, and administrative |
352 |
|
|
355 |
|
|
128 |
|
Total stock-based compensation expense before income taxes |
1,384 |
|
|
1,081 |
|
|
379 |
|
Income tax benefit |
(249) |
|
|
(179) |
|
|
(58) |
|
Total stock-based compensation expense, net of income taxes |
$ |
1,135 |
|
|
$ |
902 |
|
|
$ |
321 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions |
The weighted-average estimated fair value of employee stock options granted during 2023, 2022 and 2021 was $53.72, $44.35 and $46.07 per share, respectively, using the following assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 30, 2023 |
|
December 31, 2022 |
|
December 25, 2021 |
Expected volatility |
52.36% - 52.42% |
|
51.28 |
% |
|
51.77 |
% |
Risk-free interest rate |
3.93% - 4.11% |
|
3.00 |
% |
|
0.69 |
% |
Expected dividends |
— |
% |
|
— |
% |
|
— |
% |
Expected life (in years) |
4.96 - 5.04 |
|
4.75 |
|
4.55 |
The weighted-average grant date fair values of PRSUs granted during 2023, 2022 and 2021 were $134.87, $121.12 and $153.89, respectively, using the following assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 30, 2023 |
|
December 31, 2022 |
|
December 25, 2021 |
Expected volatility |
51.12% - 56.22% |
|
50.65% - 53.51% |
|
57.75 |
% |
Risk-free interest rate |
4.30% - 4.36% |
|
1.14% - 3.17% |
|
0.43 |
% |
Expected dividends |
— |
% |
|
— |
% |
|
— |
% |
Expected term (in years) |
2.17 - 3.00 |
|
2.07 - 3.07 |
|
3.00 |
|
Schedule of Share-based Compensation, Stock Options, Activity |
The following table summarizes stock option activity and related information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding Number of Shares |
|
Weighted- Average Exercise Price |
|
Aggregate Intrinsic Value |
|
Weighted-Average Remaining Contractual Life (in years) |
|
(In millions, except share price) |
|
|
Balance as of December 31, 2022 |
4 |
|
|
$ |
42.35 |
|
|
|
|
|
Granted |
1 |
|
|
$ |
108.19 |
|
|
|
|
|
Canceled |
— |
|
|
$ |
98.54 |
|
|
|
|
|
Exercised |
(2) |
|
|
$ |
18.22 |
|
|
|
|
|
Balance as of December 30, 2023 |
3 |
|
|
$ |
68.33 |
|
|
$ |
205 |
|
|
3.87 |
Exercisable December 30, 2023 |
2 |
|
|
$ |
49.54 |
|
|
$ |
164 |
|
|
2.73 |
|
Schedule of Share-based Compensation, Restricted Stock Units, Activity |
The following table summarizes time-based RSU activity and related information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares |
|
Weighted- Average Grant Date Fair Value |
|
|
|
|
|
(In millions) |
|
|
|
|
|
|
Unvested shares as of December 31, 2022 |
28 |
|
|
$ |
95.49 |
|
|
|
|
|
Granted |
16 |
|
|
$ |
106.28 |
|
|
|
|
|
Forfeited |
(2) |
|
|
$ |
99.48 |
|
|
|
|
|
Vested |
(10) |
|
|
$ |
99.83 |
|
|
|
|
|
Unvested shares as of December 30, 2023 |
32 |
|
|
$ |
100.65 |
|
|
|
|
|
|
Schedule of Nonvested Performance-based Units Activity |
The following table summarizes PRSU activity and related information:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares |
|
Weighted-Average Grant Date Fair Value |
|
|
|
|
|
(In millions) |
|
|
|
|
|
|
Unvested shares as of December 31, 2022 |
2 |
|
|
$ |
110.31 |
|
|
|
|
|
Granted |
1 |
|
|
$ |
134.87 |
|
|
|
|
|
Forfeited |
— |
|
|
$ |
134.53 |
|
|
|
|
|
Vested |
(1) |
|
|
$ |
129.78 |
|
|
|
|
|
Unvested shares as of December 30, 2023 |
2 |
|
|
$ |
117.65 |
|
|
|
|
|
|
Schedule of ESPP |
The weighted-average grant date fair value for the ESPP during 2023, 2022 and 2021 was $31.11, $24.71 and $27.27 per share, respectively, using the following assumptions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 30, 2023 |
|
December 31, 2022 |
|
December 25, 2021 |
|
|
|
|
Expected volatility |
45.74% - 49.40% |
|
58.15% - 63.76% |
|
36.90% - 39.39% |
|
|
|
|
Risk-free interest rate |
5.13% - 5.46% |
|
1.43% - 4.52% |
|
0.04% - 0.07% |
|
|
|
|
Expected dividends |
— |
% |
|
— |
% |
|
— |
% |
|
|
|
|
Expected term (in years) |
0.50 |
|
0.50 |
|
0.50 |
|
|
|
|
|